Home > Healthcare > Pharmaceuticals > Finished Drug Form > Progesterone Market
Progesterone Market size was valued at USD 1.3 billion in 2023 and is estimated to grow at a CAGR of 12.7% between 2024 and 2032. High market growth can be attributed to the increasing incidence of hormonal disorders such as polycystic ovary syndrome (PCOS) and endometriosis. For instance, as per the WHO, endometriosis affects roughly 10% (190 million) of reproductive age women and girls globally.
Similarly, as per the Office on Women Health (OASH), more than 11% of American women between 15 and 44 are affected with endometriosis. Such high occurrence of hormone disorders is driving the demand for progesterone-based therapies. Additionally, rising incidences of infertility and the growing adoption of assisted reproductive technologies (ART) contribute significantly to the expansion of the market. Furthermore, the aging population worldwide, coupled with the rising prevalence of menopausal symptoms, fuels the demand for hormone replacement therapies (HRT).
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Progesterone Market Size in 2023: | USD 1.3 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 12.7% |
2032 Value Projection: | USD 3.6 Billion |
Historical Data for: | 2018 – 2023 |
No. of Pages: | 210 |
Tables, Charts & Figures: | 353 |
Segments covered: | Formulation, Route of Administration, Application, Drug Type, Type, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Progesterone is a female hormone primarily produced by the ovaries, although it is also produced in smaller amounts by the adrenal glands and the placenta during pregnancy. It plays a crucial role in the menstrual cycle and in maintaining pregnancy.